Reset Map3 Results
Byk-Gulden-Str. 2 Konstanz, 78467 GermanyJiuzhou Pharma is a global CDMO specialising in small-molecule and peptide API development, process optimisation, analytical services, and GMP manufacturing. Our laboratories provide route-scouting, scalable process development, solid-state characterisation, and full analytical method development and validation services. We support advanced chemistry including asymmetric catalysis, flow chemistry, fluorination, enzymatic catalysis, cryogenic and high-pressure reactions, and HPAPI development (OEB4/OEB5). Our peptide laboratories offer SPPS and LPPS synthesis, purification, characterisation, and lyophilisation for research through development, to full-scale commercial supply. Solid-state capabilities include polymorph screening, crystallisation development, and salt-form selection. Jiuzhou’s GMP facilities enable seamless scale-up from milligram to commercial tonnes, supported by a full CMC and regulatory team experienced with global filings (DMF, CEP, ANDA, IND). We also provide early formulation development for oral solid dose and semi-solid products. We offer integrated DS–DP services, rapid technology transfer, cost-efficient manufacturing in a mature GMP network, and reliable global supply to more than 90 countries. State of the art Process R & D facility at our Konstanz site in Germany. Small but rapidly growing team of top European PhD Chemists. High -throughput and -data workflow makes this team highly competitive and fast. Particular expertise in small molecule new route identification and development, and route optimisation. Jiuzhou Pharma’s ESG strategy is anchored in science-based GHG reduction targets, renewable energy adoption, supply-chain engagement, robust governance, and international benchmarks and recognitions. Our framework reflects best practices in the pharmaceutical sector for environmental and social responsibility. As evidenced by external independent recognition: Inclusion in the FTSE4Good Index, improved ESG ratings from the London Stock Exchange Group, EcoVadis Gold Medal, AA rating from Wind, validation of GHG emission targets by the SBTi.
No.99 Waisha Road, Jiaojiang Taizhou city, Zhejiang, 318000 ChinaJiuzhou Pharma is a global CDMO specialising in small-molecule and peptide API development, process optimisation, analytical services, and GMP manufacturing. Our laboratories provide route-scouting, scalable process development, solid-state characterisation, and full analytical method development and validation services. We support advanced chemistry including asymmetric catalysis, flow chemistry, fluorination, enzymatic catalysis, cryogenic and high-pressure reactions, and HPAPI development (OEB4/OEB5). Our peptide laboratories offer SPPS and LPPS synthesis, purification, characterisation, and lyophilisation for research through development, to full-scale commercial supply. Solid-state capabilities include polymorph screening, crystallisation development, and salt-form selection. Jiuzhou’s GMP facilities enable seamless scale-up from milligram to commercial tonnes, supported by a full CMC and regulatory team experienced with global filings (DMF, CEP, ANDA, IND). We also provide early formulation development for oral solid dose and semi-solid products. We offer integrated DS–DP services, rapid technology transfer, cost-efficient manufacturing in a mature GMP network, and reliable global supply to more than 90 countries. State of the art Process R & D facility at our Konstanz site in Germany. Small but rapidly growing team of top European PhD Chemists. High -throughput and -data workflow makes this team highly competitive and fast. Particular expertise in small molecule new route identification and development, and route optimisation. Jiuzhou Pharma’s ESG strategy is anchored in science-based GHG reduction targets, renewable energy adoption, supply-chain engagement, robust governance, and international benchmarks and recognitions. Our framework reflects best practices in the pharmaceutical sector for environmental and social responsibility. As evidenced by external independent recognition: Inclusion in the FTSE4Good Index, improved ESG ratings from the London Stock Exchange Group, EcoVadis Gold Medal, AA rating from Wind, validation of GHG emission targets by the SBTi.
158 McLean Rd Brevard, NC, 28712 9432 United StatesJiuzhou Pharma is a global CDMO specialising in small-molecule and peptide API development, process optimisation, analytical services, and GMP manufacturing. Our laboratories provide route-scouting, scalable process development, solid-state characterisation, and full analytical method development and validation services. We support advanced chemistry including asymmetric catalysis, flow chemistry, fluorination, enzymatic catalysis, cryogenic and high-pressure reactions, and HPAPI development (OEB4/OEB5). Our peptide laboratories offer SPPS and LPPS synthesis, purification, characterisation, and lyophilisation for research through development, to full-scale commercial supply. Solid-state capabilities include polymorph screening, crystallisation development, and salt-form selection. Jiuzhou’s GMP facilities enable seamless scale-up from milligram to commercial tonnes, supported by a full CMC and regulatory team experienced with global filings (DMF, CEP, ANDA, IND). We also provide early formulation development for oral solid dose and semi-solid products. We offer integrated DS–DP services, rapid technology transfer, cost-efficient manufacturing in a mature GMP network, and reliable global supply to more than 90 countries. State of the art Process R & D facility at our Konstanz site in Germany. Small but rapidly growing team of top European PhD Chemists. High -throughput and -data workflow makes this team highly competitive and fast. Particular expertise in small molecule new route identification and development, and route optimisation. Jiuzhou Pharma’s ESG strategy is anchored in science-based GHG reduction targets, renewable energy adoption, supply-chain engagement, robust governance, and international benchmarks and recognitions. Our framework reflects best practices in the pharmaceutical sector for environmental and social responsibility. As evidenced by external independent recognition: Inclusion in the FTSE4Good Index, improved ESG ratings from the London Stock Exchange Group, EcoVadis Gold Medal, AA rating from Wind, validation of GHG emission targets by the SBTi.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.